Suppression of GH secretion in pituitary gigantism by continuous subcutaneous octreotide infusion in a pubertal boy-Reference-Cited by-同舟云学术

Suppression of GH secretion in pituitary gigantism by continuous subcutaneous octreotide infusion in a pubertal boy

Published:2007-01-02 Issue:1 Volume:88 Page:29-33
ISSN:0803-5253
Container-title:Acta Paediatrica
language:en
Short-container-title:

Author:

Näntö-Salonen K,Koskinen P,Sonninen P,Toppari J

Publisher

Wiley

Subject

General Medicine,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1651-2227.1999.tb01263.x/fullpdf

Reference14 articles.

1. Pituitary gigantism caused by growth hormone excess from infancy;Gelber;J Pediatr,1992

2. Management of pituitary gigantism. The role of bromocriptine and radiotherapy;Ritzen;Acta Paediatr Scand,1985

3. Gigantism due to pituitary mammosomatotroph hyperplasia;Moran;N Engl J Med,1990

4. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation;Zimmerman;J Clin Endocrinol Metab,1993

5. Evidence for octreotide subcutaneously in the treatment of acromegaly;Liuzzi;J Endocrinol,1997

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disorders of growth hormone/insulin-like growth factor secretion and action;Pediatric Endocrinology;2014

2. Hormonal Therapy in Cancer;Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures;2010-11-03

3. Disorders of Growth Hormone/Insulin-like Growth Factor Secretion and Action;Pediatric Endocrinology;2008

4. Pegvisomant Treatment in a 4-Year-Old Girl with Neurofibromatosis Type 1;Hormone Research in Paediatrics;2006

5. Pegvisomant therapy in pituitary gigantism: successful treatment in a 12-year-old girl;European Journal of Endocrinology;2005-08